Home Life Sciences Sarcopenia in liver transplantation: A comprehensive bibliometric study of current research trends and future directions
Article Open Access

Sarcopenia in liver transplantation: A comprehensive bibliometric study of current research trends and future directions

  • Yang Li , Yang Xiang , Xiaoyan Yan , Changjiang Lu , Jing Huang EMAIL logo and Lei Dai EMAIL logo
Published/Copyright: October 27, 2025

Abstract

The long-term survival and quality of life of liver transplantation (LT) recipients has emerged as a critical focus, where managing sarcopenia (a syndrome of diminished muscle mass and strength) and perioperative nutrition is paramount. This study aimed to delineate the knowledge landscape and identify key research trends and potential molecular mechanisms linking LT and sarcopenia through bibliometric and bioinformatics analyses. This study employs bibliometric and bioinformatics analyses to evaluate research trends and molecular mechanisms linking LT and sarcopenia. Data were retrieved from Web of Science database, and tools such as CiteSpace, VOSviewer, and R were used for data analysis and visualization. A total of 448 studies published over the past two decades were analyzed. Our bibliometric analysis revealed geographical distribution patterns, authorship networks, journal contributions, and thematic trends related to both LT and sarcopenia. Bioinformatics analysis identified 78 biphenotypic target genes shared by LT and sarcopenia, with hub genes including IL1B, ADIPOQ, and TNF showing strong associations. Enrichment analyses further highlighted significant biological processes, such as “response to peptide hormone” and “regulation of glucose transmembrane transport,” suggesting potential molecular mechanisms underlying the interaction between LT and sarcopenia. This study highlights the importance of incorporating routine sarcopenia assessments into the clinical management of LT candidates to optimize treatment strategies. Future research should focus on elucidating the molecular pathways connecting these conditions and developing targeted interventions to improve LT patients’ outcomes and quality of life.

Graphical abstract

1 Introduction

Liver transplantation (LT) is an important therapeutic option for individuals with end-stage liver disease [13], considerably improving survival rates and quality of life [4]. Nonetheless, post-transplant complications are common among recipients [5], with muscle wasting diseases such as sarcopenia being particularly prevalent [6]. Sarcopenia, characterized by gradual loss of skeletal muscle mass and strength [7,8], has been identified as a negative factor that can impede recovery and shorten the overall survival in LT patients [9]. The relationship between LT and sarcopenia is complex, underscoring the necessity for further research to elucidate their interplay and potentially improve patient outcomes and inform clinical approaches. Recent studies in this domain have highlighted the importance of investigating molecular mechanisms underlying sarcopenia development in the context of LT [10].

Recent studies have demonstrated that preoperative muscle mass serves as a significant predictor of postoperative outcomes [11,12]. Sarcopenic patients exhibit higher rates of complications and mortality compared to their non-sarcopenic counterparts [13,14]. This correlation emphasizes the importance of personalized therapies aimed at preserving muscle mass before and after LT. However, the present research shows substantial gaps in our understanding of biochemical pathways and genetic variables related to sarcopenia in LT patients.

To overcome these challenges, we propose a multimodal research framework that integrates bibliometric analysis with biological mechanism investigation. Bibliometric analysis sheds light on the trends and hotspots in the research landscape around LT and sarcopenia [2830], elucidating key patterns in publication output, authorship, and institutional contributions. This quantitative assessment establishes a foundation for identifying major study themes and prospective areas for future exploration. Concurrently, biological mechanism analysis can uncover the underlying genetic and molecular networks linking sarcopenia to LT, thereby revealing promising treatment targets.

The purpose of this work is to comprehensively analyze the association between LT and sarcopenia using a dual methodological approach that combines bibliometric insights with biological interventions. By reviewing the available literature, we aim to identify key genes and molecular pathways associated with both disorders, potentially uncovering biomarkers for early detection and intervention. Furthermore, this study seeks to enhance the current understanding of sarcopenia’s impact on liver transplant outcomes, ultimately guiding clinical practice toward more effective management strategies for at-risk populations.

To our knowledge, existing studies on sarcopenia in LT patients remain predominantly narrative, focusing on clinical features and management. While informative, they offer limited quantitative insight into the evolution of the field or the molecular mechanisms linking LT and sarcopenia. Our study introduces an integrative approach to address these gaps: (1) we employ bibliometrics to objectively map 20 years of research trends, collaborations, and knowledge foundations, providing a macro-analytic perspective beyond traditional reviews; (2) we further analyze transcriptomic data to identify novel hub genes and signaling pathways that may mechanistically connect LT to sarcopenia, offering new directions for basic and translational research. This dual methodology combines science mapping with mechanistic discovery, advancing the current literature both quantitatively and biologically.

2 Materials and methods

2.1 Data processing

The Web of Science (Clarivate Analytics, Philadelphia, USA) (https://webofscience.clarivate.cn/wos/alldb/basic-search) is a premier database for bibliometric analyses, recognized for its broad disciplinary coverage, precise citation indexing, and diverse analytical metrics [15,16]. These features enable researchers to identify emerging themes and trends in their respective fields. For our bibliometric analysis, we extracted publication data on LT and sarcopenia from the Web of Science Core Collection (WoSCC), specifically utilizing the Science Citation Index Expanded (SCIE) and Social Sciences Citation Index (SSCI) editions. To minimize bias arising from data updates, all search, extraction, and downloading activities were conducted on the same day. Our literature review focused exclusively on articles and reviews, with the search methods, results, and terminology [1719] detailed in Figure 1.

Figure 1 
                  Flowchart of bibliometric analysis. The flowchart demonstrated the detailed search strategy, inclusion and exclusion criteria, and analysis software. WOSCC: web of science core collection; SCIE: science citation index expanded; SSCI: social science citation index.
Figure 1

Flowchart of bibliometric analysis. The flowchart demonstrated the detailed search strategy, inclusion and exclusion criteria, and analysis software. WOSCC: web of science core collection; SCIE: science citation index expanded; SSCI: social science citation index.

2.2 Search strategy

The query formulation was as follows: (1) TS = (sarcopen* OR myopeni* OR dynaponi*); (2) TS = (muscle OR muscular); (3) TS = (atroph* OR weak* OR depletion* OR loss* OR wasting*); (4) 2 AND 3; (5) 1 OR 4; (6) TS = (LT) OR (liver transplant*) OR (Liver Grafting) OR (Grafting, Liver) OR (Liver Transplant*) OR (Transplantation, Liver) OR (Transplant, Liver) OR (Transplantation, Hepatic) OR (Hepatic Transplantation*) OR (hepatic graft∗); (7) 5 AND 6. Then, three researchers (one is a Chief Physician from the LT department, one is a PhD in hepatology, and one is a senior clinical nutrition assessment specialist, all with over 10 years of experience in the field and substantial expertise in systematic literature review) independently evaluated each article to ensure the accuracy and consistency of the pre-processed data [20]. In total, 448 relevant publications were identified, and the original data, which included full records and cited references, were retrieved in text format.

2.3 Multiple analyses and visualization

In this study, we conducted a comprehensive multi-dimensional analysis of research landscape in the field of sarcopenia and LT, including publication quantity and growth rate, leading countries and institutions, high-contributing authors and journals, frequently-cited references, temporal trends of active authors and publications, keyword bursts and clustering, and thematic trends. The analyses and visualizations were conducted using Excel (version 2016, Microsoft, DC, USA) [21], R software (version 4.2.1) (https://www.r-project.org/) with the bibliometrix package [22], CiteSpace (version 6.3.R1, 64-bit, advanced) (https://citespace.podia.com/) (java-based high-performance scientific literature analysis tool) [23], and visualization of similarities viewer (VOSviewer) (version 1.6.20, CWTS, Leiden University, The Netherlands) (https://www.vosviewer.com/) (a free, open-source software for bibliometrics and scientific visualization) [24]. This multi-dimensional approach effectively elucidates the current status, focus, and trends of sarcopenia in the context of LT, providing valuable insights to enhance the understanding of this field’s dynamics and provide information on future research.

2.4 Biological mechanism analysis

GeneCards, The Human Gene Database (Weizmann institute of Science, Rehovot, Israel) (https://www.genecards.org/) [25], is a user-friendly knowledge base that provides comprehensive information on human multiple-omics data. Using this tool, we successfully retrieved gene sets associated with sarcopenia and LT. For each gene set, we filtered genes categorized as “protein coding” and a relevance score greater than 1 and performed an intersection analysis to identify genes common to both LT and sarcopenia. Subsequently, the Friends analysis [26] was employed to calculate the importance of each gene based on network topology parameters and further analyze their functions and regulatory mechanisms in relevant biological processes (BPs). Hub genes were identified from the target genes using this analysis and visualized via a cloud plot.

Furthermore, we performed enrichment analysis of hub genes, including Gene Ontology (GO), Kyoto Encyclopedia of Genes and Genomes (KEGG) [27], and Disease Ontology (DO) enrichment analyses [28]. Using the “DOSE” and “org.Hs.eg.db” packages (version 3.24.2), we explored potential disease categories related to the hub genes in DO analysis. GO analysis provided detailed insights into the BPs, cellular components (CCs), and molecular functions (MFs) associated with the hub genes, while KEGG enrichment analysis investigated the pathways and mechanisms linked to these genes.

Additionally, we analyzed the functional protein association networks of the hub genes using the STRING database (https://cn.string-db.org/) [29]. The analysis was performed with the following parameters: maximum false discovery rate ≤0.05, minimum signal ≥0.01, and minimum strength ≥0.01. Reactome pathway analysis [30] and tissue expression (TISSUES) enrichment analyses were also conducted. These analyses collectively suggested potential pathways and future research directions from a biological mechanism perspective.

3 Results

Figure 1 illustrates the detailed workflow and results of the literature identification and screening process.

3.1 Worldwide overview

According to our search strategy, a total of 448 studies related to LT and sarcopenia (321 articles and 127 reviews) were retrieved from the WoSCC database over the past two decades. These publications received significant contributions from 47 countries and regions, 664 institutions, 2,546 authors, and 146 journals.

3.2 Publication metrics analysis

By evaluating the number of publications in the fields of LT and sarcopenia over the years, we visualized the publication trends using Excel (version 2019) and constructed a bivariate linear equation to predict future trends (Figure 2a):

y = 0.2199 t 2 882.42 t + 885192 ( R 2 = 0.9715 ) .

Figure 2 
                  Distribution and growth trend of publications about sarcopenia and LT. (a) Increasing trends in annual publications from 2004 to 2024 with a polynomial function and fitted curve by using Microsoft Excel 2019. (b) Annual cumulative number of publications from 2004 to 2024.
Figure 2

Distribution and growth trend of publications about sarcopenia and LT. (a) Increasing trends in annual publications from 2004 to 2024 with a polynomial function and fitted curve by using Microsoft Excel 2019. (b) Annual cumulative number of publications from 2004 to 2024.

Based on this model, the field is expected to experience sustained exponential growth in the coming years. Additionally, we identified 2014 as a significant turning point, dividing the publication growth rate and total volume into two phases: Period I (2004–2013) and Period II (2014–2024). During Period I, the annual publication volume was below ten, with the growth rate approaching zero. However, since 2014, publications have grown rapidly, with the volume in 2024 expected to be 3.15 times higher than that in 2014. Furthermore, the total volume over the next decade is predicted to increase by a factor of 9.79 compared to the previous decade (Figure 2b). This accelerated growth suggests that the field is garnering increasing scientific attention, which is likely to accelerate the overcoming of existing research bottlenecks.

3.3 Analysis of the distribution of countries and institutions

Our analysis revealed that the total number of publications from the top ten countries in this field was nearly three times greater than the total output from other countries. Notably, the United States led in both publication volume (n = 130) and citation count (n = 7,354). Among the top ten countries, 70% were from Europe and North America, while 30% were from Asia, with the publications of the former exceeding those of the latter by a factor of 2.4. Among Asian countries, Japan had the highest publication volume (n = 61) and citation count (n = 2,451), while China ranked fifth with 43 publications and 693 citations but had the lowest average citation per publication (16.12). Although Canada ranked third in publication volume, it held the highest average citation per publication (70.85) (Table 1). Additionally, overlay visualization revealed that publications from the United States and Japan were relatively early (2018–2019), while other European and North American countries published mainly during 2020–2021. China saw a sharp increase in publication volume starting in 2022 (Figure 3a). Network analysis also showed that international collaborations were primarily concentrated among the top ten countries.

Table 1

Top ten countries and institutions on research of sarcopenia and LT

Rank Country Documents Citations Average number of citations/publications Institution Documents Citations Average number of citations/publications
1 USA 130 7,354 56.57 University of Alberta 34 2,273 66.85
2 Japan 61 2,451 40.18 University of California, San Francisco 30 1,941 64.70
3 Canada 59 4,180 70.85 University of Pittsburgh 24 1433 59.71
4 Italy 43 1,335 31.05 Kyoto University 23 1,385 60.22
5 Peoples’ R China 43 693 16.12 University of Alberta Hospital 15 2,034 135.60
6 South Korea 29 682 23.52 Cleveland clinic 13 1,737 133.62
7 Spain 27 514 19.04 University of Toronto 12 336 28.00
8 England 26 715 27.50 Mayo clinic 12 854 71.17
9 The Netherlands 17 837 49.24 UCLA 11 494 44.91
10 Germany 17 671 39.47 University of Michigan 11 1,221 111.00
Figure 3 
                  Network visualization of geography, institutions, and authors on research related to sarcopenia and LT. (a) Network map of countries on research of sarcopenia and LT. (b) Network map of institutions on research of sarcopenia and LT. (c) Network map of authors on research of sarcopenia and LT. (d) Network map of co-cited authors on research of sarcopenia and LT.
Figure 3

Network visualization of geography, institutions, and authors on research related to sarcopenia and LT. (a) Network map of countries on research of sarcopenia and LT. (b) Network map of institutions on research of sarcopenia and LT. (c) Network map of authors on research of sarcopenia and LT. (d) Network map of co-cited authors on research of sarcopenia and LT.

Half of the top ten contributing institutions in this field were based in the United States, with only one institution from Japan, Kyoto University (Rank 4, 23 publications and 1,385 citations). The University of Alberta in Canada has produced the highest number of publications in the last 20 years (34 publications and 2,273 citations). However, in terms of average citation per publication, University Alberta Hospital (135.60), Cleveland Clinic (133.62), and University of Michigan (111.00) all exceed 100, far outperforming other institutions (Table 2). Similarly, we found that these leading institutions published relatively early, mainly between 2017 and 2019. Moreover, network analysis revealed that institutions in North America had close collaborative ties, while Japanese institutions were relatively isolated (Figure 3b).

Table 2

Top ten authors and co-cited authors on research of sarcopenia and LT

Rank Author Documents Citations Average number of citations/publications H-index G-index Co-cited authors Citations
1 LAI, JENNIFER C. 27 1,908 70.67 18 27 MONTANO-LOZA, ALDO J. 524
2 MONTANO-LOZA, ALDO J. 24 3,457 144.04 22 25 LAI, JENNIFER C. 442
3 KAIDO, TOSHIMI 22 1,082 49.18 14 23 TANDON, PUNEETA 317
4 UEMOTO, SHINJI 20 1,059 52.95 13 20 CAREY, ELIZABETH J 215
5 YAGI, SHINTARO 15 412 27.47 9 15 DASARATHY, SRINIVASAN 198
6 TANDON, PUNEETA 15 1,482 98.80 13 15 VAN VUGT, JEROEN L. A. 189
7 DUARTE-ROJO, ANDRES 15 911 60.73 11 15 CRUZ-JENTOFT AJ 188
8 DUNN, MICHAEL A. 14 1,049 74.93 13 14 HAMAGUCHI, YUHEI 180
9 KAMO, NAOKO 13 386 29.69 9 13 KAIDO, TOSHIMI 174
10 SHIRAI, HISAYA 12 394 32.83 9 12 SINCLAIR, MARIE 168

3.4 Analysis of authors’ and co-cited authors’ distribution

The top ten contributing authors were predominantly from medical institutions in the United States, Canada, and Japan, with half of them being Japanese scholars. An interesting observation was that these five Japanese scholars were all affiliated with Kyoto University and collaborated closely with one another. They had co-authored a total of 82 publications in the fields of LT and sarcopenia, which had been cited 3,333 times. To further assess their academic impact, we used the H-index (which balances the quantity and overall quality of an author’s publications) and the G-index (which emphasizes the influence of highly cited articles). Among the top contributors, LAI, JENNIFER C from the University of California, San Francisco, USA, had published the most articles (n = 27) and had the highest G-index (n = 27). Meanwhile, MONTANO-LOZA, ALDO J from the University of Alberta in Canada had the most citations (n = 3,457), with an average citation per publication of 144.04, an H-index of 22, and a G-index of 25, all of which were high (Table 2). Additionally, network analysis revealed that Japanese scholars published earlier (2017–2018), while their European and American counterparts focused more on publications post-2019, and there was a lack of close academic collaboration between the two groups (Figure 3c).

We further explored the collaborative relationships within the academic community using co-citation analysis, which refers to the simultaneous citation of two or more articles by subsequent research. Among the top ten authors with high contributions, four were also with high co-citations. MONTANO-LOZA, ALDO J had the highest co-citation count (n = 524), followed by LAI, JENNIFER C (n = 442) and TANDON, PUNEETA (n = 317) (Table 2). Similar to the high-contributing authors, the high co-cited authors were primarily clustered into two categories: one consisting of European and American scholars and the other of Japanese scholars (Figure 3d).

3.5 Analysis of references and co-cited references

We summarized the key information of the top ten highly cited and highly co-cited references in Tables 3 and 4. The results showed that all of the top ten highly cited references had been cited more than 250 times, with the first-ranked reference by ENGLESBE MJ (DOI: 10.1016/j.jamcollsurg.2010.03.039) and the second-ranked reference by MONTANO-LOZA AJ (DOI: 10.1016/j.cgh.2011.08.028), both having been cited over 600 times. All references focused on the assessment of muscle mass and prognostic factors in LT patients. Notably, three references proposed integrating the model for end-stage liver disease (MELD) score with sarcopenia into the LT evaluation system (seventh, nineth, and tenth ranks), while two others suggested criteria or thresholds for muscle wasting (fifth and sixth ranks) (Table 3).

Table 3

Top ten references with highest citations on research of sarcopenia and LT

Rank Author Title Key point DOI Total Citation Journal Year
1 ENGLESBE MJ Sarcopenia and mortality after liver transplantation Sarcopenia assessment 10.1016/j.jamcollsurg.2010.03.039 621 J AM COLL SURGEONS 2010
LT outcomes
Psoas muscle area
Post-transplantation mortality
Patient frailty indicators
2 MONTANO-LOZA AJ Muscle wasting is associated with mortality in patients with cirrhosis Sarcopenia prevalence 10.1016/j.cgh.2011.08.028 606 CLIN GASTROENTEROL H 2012
Liver cirrhosis
Mortality prediction
LT evaluation
Muscle mass assessment
3 TANDON P Severe muscle depletion in patients on the liver transplant wait list: its prevalence and independent prognostic value Sarcopenia prevalence 10.1002/lt.23495 430 LIVER TRANSPLANT 2012
LT candidates
Prognostic significance
Waiting list mortality
Muscle depletion predictors
4 DASARATHY S Sarcopenia from mechanism to diagnosis and treatment in liver disease Sarcopenia in cirrhosis 10.1016/j.jhep.2016.07.040 396 J HEPATOL 2016
Muscle mass assessment
LT outcomes
Mortality risk
Therapeutic targets
5 HAMAGUCHI Y Proposal for new diagnostic criteria for low skeletal muscle mass based on computed tomography imaging in Asian adults Sarcopenia assessment in LT 10.1016/j.nut.2016.04.003 361 NUTRITION 2016
Psoas muscle mass index (PMI) as a predictor
Sex-specific cutoff values for low skeletal muscle mass
Sarcopenia’s impact on post-transplant survival
Asian population criteria for sarcopenia
6 CAREY EJ A multicenter study to define sarcopenia in patients with end-stage liver disease Sarcopenia definition 10.1002/lt.24750 339 LIVER TRANSPLANT 2017
LT
SMI
Wait-list mortality
Muscle wasting thresholds
7 LAI JC Development of a novel frailty index to predict mortality in patients with end-stage liver disease Frailty index for cirrhosis 10.1002/hep.29219 330 HEPATOLOGY 2017
LT candidates
Mortality prediction
MELD score supplementation
Extrahepatic complications
8 KAIDO T Impact of Sarcopenia on Survival in Patients Undergoing Living Donor Liver Transplantation Sarcopenia assessment 10.1111/ajt.12221 303 AM J TRANSPLANT 2013
Living donor liver transplantation (LDLT)
Post-transplantation mortality
Muscle mass correlation
Perioperative nutritional therapy
9 DURAND F Prognostic value of muscle atrophy in cirrhosis using psoas muscle thickness on computed tomography Sarcopenia and mortality 10.1016/j.jhep.2014.02.026 284 J HEPATOL 2014
LT
MELD score
Psoas muscle thickness (TPMT)
Prognostic marker
10 VAN VUGT JLA Systematic Review and Meta-analysis of the Impact of Computed Tomography–Assessed Skeletal Muscle Mass on Outcome in Patients Awaiting or Undergoing Liver Transplantation Sarcopenia assessment 10.1111/ajt.13732 260 AM J TRANSPLANT 2016
LT outcomes
MELD score supplementation
Muscle waste as a prognostic marker
Preoperative skeletal muscle mass and survival
Table 4

Top ten co-cited references on research of sarcopenia and liver transplantation

Rank Author Title Key point DOI Total Citation Journal Year
1 MONTANO-LOZA AJ Muscle wasting is associated with mortality in patients with cirrhosis Sarcopenia prevalence 10.1016/J.CGH.2011.08.028 144 CLIN GASTROENTEROL H 2012
Liver cirrhosis
Mortality prediction
LT evaluation
Muscle mass assessment
2 ENGLESBE MJ Sarcopenia and mortality after liver transplantation Sarcopenia assessment 10.1016/J.JAMCOLLSURG.2010.03.039 138 J AM COLL SURGEONS 2010
LT outcomes
Psoas muscle area
Post-transplantation mortality
Patient frailty indicators
3 TANDON P Severe muscle depletion in patients on the liver transplant wait list: Its prevalence and independent prognostic value Sarcopenia prevalence 10.1002/LT.23495 119 LIVER TRANSPLANT 2012
LT candidates
Prognostic significance
Waiting-list mortality
Muscle depletion predictors
4 CAREY EJ A multicenter study to define sarcopenia in patients with end-stage liver disease Sarcopenia definition 10.1002/LT.24750 109 LIVER TRANSPLANT 2017
LT
SMI
Wait-list mortality
Muscle wasting thresholds
5 MONTANO-LOZA AJ Severe muscle depletion predicts postoperative length of stay but is not associated with survival after liver transplantation Sarcopenia in cirrhosis 10.1002/LT.23863 105 LIVER TRANSPLANT 2014
LT outcomes
Mortality prediction
Post-transplant complications
Muscle mass assessment
6 CRUZ-JENTOFT AJ Sarcopenia: European consensus on definition and diagnosis Sarcopenia definition and diagnosis 10.1093/AGEING/AFQ034 97 AGE AGEING 2010
European Working Group on Sarcopenia in Older People (EWGSOP) criteria
Muscle mass and function assessment
Clinical utility and statistical accuracy balance
Mortality prediction in cirrhosis patients
7 DURAND F Prognostic value of muscle atrophy in cirrhosis using psoas muscle thickness on computed tomography Sarcopenia and mortality 10.1016/J.JHEP.2014.02.026 95 J HEPATOL 2014
LT
MELD score
Psoas muscle thickness (TPMT)
Prognostic marker
8 VAN VUGT JLA Systematic Review and Meta-analysis of the Impact of Computed Tomography–Assessed Skeletal Muscle Mass on Outcome in Patients Awaiting or Undergoing Liver Transplantation Sarcopenia assessment 10.1111/AJT.13732 92 AM J TRANSPLANT 2016
LT outcomes
MELD score supplementation
Muscle waste as a prognostic marker
Preoperative skeletal muscle mass and survival
9 KAIDO T Impact of Sarcopenia on Survival in Patients Undergoing Living Donor Liver Transplantation Sarcopenia assessment 10.1111/AJT.12221 91 AM J TRANSPLANT 2013
LDLT
Post-transplantation mortality
Muscle mass correlation
Perioperative nutritional therapy
10 MONTANO-LOZA AJ Inclusion of sarcopenia within MELD (MELD-Sarcopenia) and the prediction of mortality in patients with cirrhosis Sarcopenia impact on LT 10.1038/CTG.2015.31 91 CLIN TRANSL GASTROEN 2015
MELD score limitations
Muscularity assessment improvement
Mortality prediction in cirrhosis
Sarcopenia as a prognostic indicator

Six of the top ten highly cited references were also among the top ten most co-cited references. Particularly, we found that ENGLESBE MJ (DOI: 10.1016/j.jamcollsurg.2010.03.039), MONTANO-LOZA AJ (DOI: 10.1016/j.cgh.2011.08.028), and TANDON P (DOI: 10.1002/lt.23495) not only ranked among the top three highly cited references but also ranked among the top three most co-cited references. Furthermore, we observed that MONTANO-LOZA AJ had the greatest impact, as three of the top ten most co-cited references were his works. In his 2014 article in “LT” (DOI: 10.1002/LT.23863), he presented a new and critical viewpoint: severe sarcopenia may not be linked to outcomes after LT (Table 4). However, all of these high-impact articles were clinical studies, and there is currently a lack of basic research exploring the underlying mechanisms between sarcopenia and LT.

3.6 Time zone analysis of authors and timeline analysis of references

To gain a comprehensive understanding of the distribution of authors, collaboration networks, and the dynamic evolution of research hotspots in the fields of sarcopenia and LT, we performed a temporal analysis of the authors in this domain. The results revealed that representative authors can be categorized into three distinct periods. In the first period, Montano-Loza, Aldo J, emerged as a leading figure, driving the surge in publications in 2012. According to the author’s annual ring analysis, Montano-Loza, Aldo J not only published extensively but also achieved a high citation rate, maintaining significant scholarly attention in subsequent years. The second period, spanning from 2016 to 2019, was marked by a dramatic increase in publications, with key figures such as Lai, Jennifer C, and Kaido, Toshimi becoming prominent contributors. This phase witnessed the rise of numerous highly cited scholars, reflecting a shift toward a more diversified authorship landscape compared to the first period, where one prominent author stood out. Additionally, collaborations among various academic groups strengthened during this time, particularly within Asian academic circles, with Japan rapidly gaining prominence. In the following 2 years, the field experienced a temporary decline in research activity until the third phase began in 2022, when the research trend revived. During this phase, new scholars formed tight-knit collaborations, and citations continued to rise. However, the long-term significance and value of research conducted during this phase remain to be determined through future assessments (Figure 4a).

Figure 4 
                  Visualized analysis of time zone and timeline. (a) Time zone map of authors on research of sarcopenia and LT. (b) Timeline map of references on research of sarcopenia and LT.
Figure 4

Visualized analysis of time zone and timeline. (a) Time zone map of authors on research of sarcopenia and LT. (b) Timeline map of references on research of sarcopenia and LT.

We conducted a more detailed global analysis of the evolving research hotspots in this field through a timeline graph. The results revealed that research in this domain has been particularly concentrated since 2012, forming 17 distinct thematic clusters (Figure 4b). Themes such as #0 Enhanced Recovery, #1 Emerging Awareness, #3 Adverse Event, #4 Assessing Nutrition, #7 Muscle Wasting, #11 Chronic Allograft, and #17 Sarcopenic Overweight have gained increasing attention over time, reflecting their growing prominence in the past decade. Classical LT-related topics, such as #8 Undergoing LT, #9 Turning Challenge, and #10 Liver Frailty Index, have continued to attract sustained attention. Notably, the most representative articles for each of these themes are among the top ten most-cited publications in the field.

3.7 Analysis of journals’ and co-cited journals’ distribution

We performed a statistical analysis of 146 journals that published literature in the fields of sarcopenia and LT over the past two decades. Among these, *LT* had the highest publication volume (n = 38; 22.9%) and received the most citations (n = 3,039; 35.1%). Among the top ten highly cited journals, eight are ranked in the Q1 quartile of the Journal Citation Reports (JCR), indicating their high recognition and strong willingness to disseminate research in this field. All eight of these journals have an impact factor greater than four, with *Journal of Hepatology* having the highest impact factor (IF = 26.8). Its citation count ranked second only to *LT* (n = 1,599, 18.5%), with 12 publications (7.2%). Following closely was *Hepatology* (IF = 12.9), with 1,062 citations (12.3%) and 9 publications (5.4%). Although these two journals ranked eighth and tenth in terms of total publications, their average citations per publication ranked first (n = 133.25) and second (n = 118.00), respectively (Table 5). This suggests that these prestigious journals have rigorous manuscript selection processes and that the published articles possess high scientific value. These journals were closely interconnected, and based on the publication timeline, we can categorize them into four distinct periods:

  1. The 2019.0–2019.5 period, represented by *LT*, *Nutrition*, and *Transplantation Proceedings*.

  2. The 2019.5–2020.0 period, represented by *Clinical Transplantation* and *World Journal of Gastroenterology*.

  3. The 2020.0–2020.5 period, during which *Liver International* (IF = 6.0; Q1) and *American Journal of Transplantation* (IF = 8.9; Q1) led with high publication volumes.

  4. The 2020.5–2021.0 period, during which journals such as *Nutrients* (IF = 4.8, Q1) showed sustained growth in publication volume (Figure 5a).

Table 5

Top ten journals and co-cited journals on research of sarcopenia and LT

Rank Journal Documents Citations Average number of citations/publications JIF (2024) JCR Co-cited Journal Co-citations JIF (2024) JCR
1 Liver Transplantation 38 3,039 79.97 4.7 Q1 Journal of Liver Transplantation 1,806 4.7 Q1
2 Clinical Transplantation 20 402 20.10 1.9 Q3 Hepatology 1,380 12.9 Q1
3 Transplantation Proceedings 18 120 6.67 0.8 Q4 Journal of Hepatology 1,251 26.8 Q1
4 World Journal of Gastroenterology 17 684 40.24 4.3 Q1 American Journal of Transplantation 780 8.9 Q1
5 Nutrients 16 279 17.44 4.8 Q1 Transplantation 638 5.3 Q1
6 Liver International 13 272 20.92 6.0 Q1 Clinical Gastroenterology and Hepatology 495 11.6 Q1
7 Transplantation 13 501 38.54 5.3 Q1 Journal of Cachexia, Sarcopenia and Muscle 495 9.4 Q1
8 Journal of Hepatology 12 1,599 133.25 26.8 Q1 Gastroenterology 455 25.7 Q1
9 American Journal of Transplantation 10 707 70.70 8.9 Q1 Liver International 409 6.0 Q1
10 Hepatology 9 1,062 118.00 12.9 Q1 Nutrition 391 3.2 Q2

JIF, journal impact factor; JCR, journal citation reports.

Figure 5 
                  Network visualization of journals and co-cited journals. (a) Network map of journals on research of sarcopenia and LT. (b) Network map of co-cited journals on research of sarcopenia and LT. (c) Dual-map overlay of journals on research of sarcopenia and LT (left: clustering of citing journals; right: clustering of cited journals; colored path: citation relationships between the citing journals and the cited journals).
Figure 5

Network visualization of journals and co-cited journals. (a) Network map of journals on research of sarcopenia and LT. (b) Network map of co-cited journals on research of sarcopenia and LT. (c) Dual-map overlay of journals on research of sarcopenia and LT (left: clustering of citing journals; right: clustering of cited journals; colored path: citation relationships between the citing journals and the cited journals).

Regarding co-cited journal analysis, nine out of the top ten journals were in the Q1 quartile, with only one in Q2. Four journals had an impact factor exceeding 10, and two surpassed 20. Notably, 50% of the journals exhibited a co-citation count greater than 500. Among these, *LT* led with the highest co-citation frequency (n = 1,806; 22.3%), followed by *Hepatology* (n = 1,380; 17.0%), *Journal of Hepatology* (n = 1,251; 15.4%), *American Journal of Transplantation* (n = 780; 9.6%), and *Transplantation* (n = 638; 7.9%) (Table 5). A co-citation network diagram further revealed robust, intricate, and tightly interconnected co-citation relationships among the top 10 journals (highlighted by yellow circles) (Figure 5b).

The dual-map overlay serves as a tool to visualize citation link mapping from the global citing base map to the global cited base map. Using this method, we analyzed the citation relationships between different journals and their distribution across various disciplines. As depicted in Figure 5c, two primary green citation paths represented the literature published in Molecular/Biology/Genetics (z-value = 1.85; f-value = 121,667) and Health/Nursing/Medicine, both predominantly cited by literature within the Medicine/Medical/Clinical field.

3.8 Analysis of keyword bursts

To comprehensively and accurately identify the core themes, research trends, and emerging directions in the field, we conducted a co-occurrence analysis combining keywords and author keywords. The top 25 author keyword network was visualized using a density diagram. We observed that keywords centered around LT, along with physical condition-related terms (e.g., body composition, obesity, exercise, prehabilitation, and nutritional status) (green), emerged early and have remained a focus of sustained attention, representing classic themes in the field. In contrast, keywords centered around sarcopenia, along with outcome-related terms, liver cirrhosis, and physical evaluation (e.g., psoas muscle index and physical activity) (red), likely represent emerging research directions or hot topics. Furthermore, research related to complications and infections is relatively sparse (blue), while studies on frailty, hepatology, muscle, and similar topics are more abundant (yellow). Notably, keywords such as myostatin, inflammation, skeletal muscle, and prognosis not only frequently appeared in the literature but also emerged later (purple), indicating that these are recent research hotspots (Figure 6a).

Figure 6 
                  Visualized analysis of keyword bursts and thematic words. (a) Density visualization of co-occurrence author keywords of 448 literature reports. Changes in color refer to the clustering density (core areas within the research field). (b) Burst strength and time duration of the top 25 keywords with the strongest citation bursts. (c) Thematic analysis of the field of LT and sarcopenia. (Themes are grouped into four broad categories according to their development and relevance degrees: niche themes, motor themes, emerging or declining themes, and basic themes.) (d) Conceptual structure map of keyword burst.
Figure 6

Visualized analysis of keyword bursts and thematic words. (a) Density visualization of co-occurrence author keywords of 448 literature reports. Changes in color refer to the clustering density (core areas within the research field). (b) Burst strength and time duration of the top 25 keywords with the strongest citation bursts. (c) Thematic analysis of the field of LT and sarcopenia. (Themes are grouped into four broad categories according to their development and relevance degrees: niche themes, motor themes, emerging or declining themes, and basic themes.) (d) Conceptual structure map of keyword burst.

Additionally, we analyzed the burst terms among the top 25 based on their emergence time and citation intensity. Nutritional status was identified as the earliest burst term, with the strongest citation bursts between 2012 and 2016 (Str = 6.68). This was followed by surges in research on resection (Str = 5.41) and computed tomography (Str = 5.34) during the 2013–2018 period. Emerging hotspot themes in the field began to surface during the mid-period of the 2004–2024 period, with the overall trend shifting from the clinical/nutritional status to muscle depletion/complications and eventually toward more refined sarcopenia evaluation standards (functional assessment and skeletal muscle index – SMI) (Figure 6b).

3.9 Analysis of hotpots and frontiers

We employed thematic term analysis to explore the core themes in the field of sarcopenia combined with LT. By analyzing the development and relevance degree of the terms, they were categorized into four domains: niche themes, basic themes, emerging or declining themes, and motor themes. In niche fields, themes focused on medical care (including intensive care unit length and perioperative care stay), liver diseases (e.g., hepatorenal syndrome, albumin infusion, and chronic liver disease), and protopathy and complications (e.g., chronic hepatitis C, alcoholic cirrhosis, clinical implications, esophageal varices, and fat-free mass). In classical and well-developed fields, themes were clustered into three groups: underlying mechanism (e.g., hepatocellular carcinoma, chain amino acids, risk factors, insulin resistance, and nonalcoholic steatohepatitis), assessment and intervention (e.g., quality of life, hepatic encephalopathy, exercise, muscle mass, and subjective global assessment), and epidemiology and prognosis (e.g., sarcopenia, mortality, cirrhosis, survival, and skeletal muscle) (Figure 6c). However, no themes were identified in the motor and emerging/declining fields, suggesting that these two areas may represent breakthrough opportunities for future research.

Additionally, a descending dimension method with the MCA algorithm was used to perform a re-clustering analysis of co-occurrence keywords. The resulting conceptual structure map revealed five clusters. The largest cluster, shown in blue, encompassed the majority of themes, focusing on clinical nutrition assessment, complications, transplantation, and prognosis (Figure 6d). These results are consistent with the previous analysis and further expand the understanding of the hot topics in this field from another perspective.

Furthermore, CiteSpace was used to conduct a clustering analysis of the keywords in the literature from 2004 to 2024 in this field. A total of 12 clustering themes were obtained, among which #3 impact, #6 discharge, #8 selection, #9 transcription factor foxp3, and #10 meta-analysis are new themes differing from previous analyses (Figure 7a), indicating new directions for exploration. Simultaneously, we conducted a temporal trend visualization analysis of trend topics (Figure 7b). The results are largely consistent with Figure 6b. It is particularly noteworthy that the nine topics during the period from 2019 to 2021, including sarcopenia, cirrhosis, impact, mortality, survival, outcomes, skeletal muscle, body composition, and disease, received the greatest attention and emphasis, with rapid development in research, literature, collaboration, and citations surrounding them. Overall, the focus of the topics has shifted from pathophysiology (e.g., stage liver disease, metabolism, etc.) to the current refined evaluation criteria and prognostic models (e.g., score, waitlist mortality, etc.). The shift in research hotspots indicates a change in scientists’ attitudes and approaches to research in this field, pointing to potential rapidly developing research directions and key areas in the future.

Figure 7 
                  Trend analysis of research on LT and sarcopenia. (a) Clustering analysis of keywords. (b) Timeline of topic trends in the research refers to LT and sarcopenia.
Figure 7

Trend analysis of research on LT and sarcopenia. (a) Clustering analysis of keywords. (b) Timeline of topic trends in the research refers to LT and sarcopenia.

3.10 Analysis of biological mechanisms underlying LT and sarcopenia

According to the screening criteria, we retrieved 7,295 LT-related target genes and 85 sarcopenia-related target genes from the GeneCards database. By intersecting these two datasets, we identified 78 overlapping target genes that are commonly related to both LT and sarcopenia (Figure 8a). Due to the lack of gene expression profile data, we used Friends analysis as an alternative to machine learning for further screening of hub genes that potentially play key roles in the BPs of these two disease phenotypes. As shown in the raincloud plot, the top 20 out of 78 biphenotypic genes were ranked based on gene similarity, with IL1B showing the strongest correlation with other genes (similarity index (SI) = 0.60), suggesting its potential central role. Other closely related genes included ADIPOQ, TNF, INS, IGF1, IL6, LEP, IL10, TIMP1, TP53, and CAV1, all of which demonstrated strong correlations with SI values greater than 0.5, indicating their collaborative involvement in the BPs underlying LT and sarcopenia (Figure 8b).

Figure 8 
                  Biological and genetic analyses of LT and sarcopenia. (a) Potential interactive target genes for LT and sarcopenia. (b) Friends analysis of the target genes. (c) GO analysis of the target genes. (d) KEGG analysis of the target genes. (e) DO analysis of the target genes. (f) Reactome pathway enrichment analysis of the target genes. (g) TISSUES analysis of the targets. GO: gene ontology; KEGG: Kyoto Encyclopedia of Genes and Genomes; DO: disease ontology; TISSUES: tissue expression. *P <0.05, **P <0.01, and ***P <0.001.
Figure 8

Biological and genetic analyses of LT and sarcopenia. (a) Potential interactive target genes for LT and sarcopenia. (b) Friends analysis of the target genes. (c) GO analysis of the target genes. (d) KEGG analysis of the target genes. (e) DO analysis of the target genes. (f) Reactome pathway enrichment analysis of the target genes. (g) TISSUES analysis of the targets. GO: gene ontology; KEGG: Kyoto Encyclopedia of Genes and Genomes; DO: disease ontology; TISSUES: tissue expression. *P <0.05, **P <0.01, and ***P <0.001.

To explore the potential biological mechanisms linking these two disease phenotypes, we conducted GO and KEGG enrichment analyses on the top 20 hub genes. In terms of BPs, pathways such as “response to peptide,” “regulation of monooxygenase activity,” “regulation of glucose transmembrane transport,” “regulation of nitric-oxide synthase activity,” and “regulation of smooth muscle cell proliferation” (all P.adj <0.001) were identified as the primary mechanisms involved in the progression of these diseases. CC analysis highlighted terms like “vesicle lumen,” “cytoplasmic vesicle lumen,” “secretory granule lumen,” “platelet alpha granule lumen,” “platelet alpha granule,” and “endoplasmic reticulum lumen” (all P.adj <0.01). MF analysis revealed functions such as “signaling receptor activator activity,” “receptor ligand activity,” “hormone activity,” “cytokine activity,” “protease binding,” and “growth factor activity” (all P.adj <0.001) as being closely related to these two disease phenotypes (Figure 8c). Based on KEGG pathway analysis, the key pathways primarily focused on cellular energy metabolism (e.g., AMPK signaling pathway), lipid metabolism (e.g., adipocytokine signaling pathway), endocrine metabolism (e.g., endocrine resistance), and tumor metabolism (e.g., proteoglycans in cancer) (all P.adj <0.001) (Figure 8d).

Furthermore, leveraging the disease association information of these hub genes, we constructed a disease association network. This revealed that liver diseases (e.g., fatty liver disease, liver cirrhosis), diabetes-related diseases (e.g., diabetic retinopathy, gestational diabetes), cardiovascular diseases (e.g., atherosclerotic cardiovascular disease, acute vascular disease, arteriosclerotic cardiovascular disease), and tumor-related diseases (e.g., organ system benign neoplasm and renal cell carcinoma) were significantly associated with LT and sarcopenia (all P.adj <0.001). These findings suggest the existence of common features and potential shared mechanisms among these diseases (Figure 8e).

To further elucidate the potential biomolecular mechanisms and histological distribution of these top 20 hub genes, we performed reactome pathway analysis and tissue expression (TISSUES) enrichment analyses. Beyond confirming the regulation of insulin-like growth factor (IGF) consistent with the aforementioned enrichment results, we uncovered additional precise pathways: interleukin-4/interleukin-13/interleukin-10 signaling, ghrelin BP, VEGFR2-mediated vascular permeability, regulation of TP53 degradation, CD163-mediated anti-inflammatory response, eNOS (endothelial nitric-oxide synthase) activation, SARS-CoV-2 targeting host intracellular signaling and regulatory pathways, and FOXO-mediated transcription (Figure 8f). Additionally, we found that these hub genes were predominantly enriched in adults compared to minors and infants and exhibited high expression levels in abdominal adipose tissues, the peritoneum, venous blood, capillaries, and neutrophils (Figure 8g).

4 Discussion

Sarcopenia is an age-related condition that has garnered increasing international attention [31,32]. It is closely linked to nutrition [33], liver diseases [34], cardiovascular diseases [35], and cancers [36]. In our country, sarcopenia significantly affects the survival and quality of life of patients undergoing LT for end-stage liver disease [37,38]. Both pre- and post-transplantation sarcopenia have been reported to correlate with poor postoperative outcomes, emerging as a critical research frontier. Therefore, elucidating the underlying mechanisms and interactions between sarcopenia and LT is crucial. This study innovatively integrated bibliometric analysis with bioinformatics tools, aiming to move beyond previous research that predominantly focused on surgical outcomes or mechanisms of muscle atrophy [39,40], thereby providing a multidimensional perspective on the knowledge structure, evolutionary trajectory, and future trends of this emerging field. In contrast to previous studies predominantly focused on validating prognostic associations or isolated mechanisms, the core value of this research lies in constructing a multi-level analytical framework of “macro-trends–knowledge structure–molecular network.” It organically links active research clusters, key scholarly contributions, potential driver genes, and biological pathways for the first time, thereby providing an unprecedented systematic perspective and a series of testable new hypotheses for understanding the pathogenesis of sarcopenia in the context of LT.

We identified 448 studies related to LT and sarcopenia over the past 20 years from WoSCC. Mathematical modeling of publication trends revealed a marked exponential growth in research output beginning in 2014 (Figure 2a), a pattern indicative of the field’s growing significance and momentum. This surge coincides with the initial operationalization of sarcopenia by the European Working Group on Sarcopenia in Older People (EWGSOP), which provided essential diagnostic criteria that galvanized systematic research [8]. Prior to this consensus, studies primarily emphasized the role of nutritional indicators – such as albumin and body composition – in LT prognosis [41], yet lacked standardized, objective measures for assessing sarcopenia. The establishment of consensus definitions enabled skeletal muscle evaluation to evolve into a widely adopted clinical tool for nutritional assessment, disease stratification, and prognostic prediction. Furthermore, the accelerated growth since 2014 likely reflects increasing recognition of sarcopenia as a pivotal determinant of post-LT outcomes and quality of life. Broader trends, including heightened focus on nutritional health during global public health challenges such as the COVID-19 pandemic, influenza, and monkeypox [42], may have also contributed to the expanded scientific interest in this area.

An analysis of research performance across countries and regions reveals significant geographic disparities and an evolution in collaborative patterns within the field of LT and sarcopenia research. European and North American countries dominate in both academic output (n = 309; 69.0%) and influence (n = 15,606; 64.4%), while Asian countries follow distantly (133 publications, 29.7%; 3,826 citations, 15.8%) This distribution strongly correlates with levels of economic development, healthcare infrastructure, and research investment, underscoring the role of high-resource settings in shaping global knowledge production in this domain. Notably, despite an overall increase in international collaboration, substantial barriers to cooperation persist among leading institutions. For instance, while Kyoto University in Japan is recognized as a top-contributing institution, it exhibits limited collaborative links with key North American and European research entities (Figure 3b). This relative isolation may stem from several factors: differences in study populations and disease etiology may lead to divergent research priorities; the lack of standardized diagnostic criteria may hinder comparative studies; and there may be lingering challenges in the visibility and integration of non-English speaking research communities within global academic networks. These observations highlight the need for standardized methodologies and shared data platforms to improve the generalizability and interoperability of research findings.

Furthermore, author collaboration networks reveal that some highly productive Japanese research teams exhibit a pattern of high output yet relatively limited international engagement. Their early and prolific contributions (Figure 3c) were characterized predominantly by domestic or institutional partnerships. This insular collaboration pattern may be influenced by region-specific study designs – such as a focus on single-center cohorts or Asian patient populations – as well as distinct clinical priorities. While such an approach fosters regional research identity and may address local health concerns, it may also limit the global dissemination and integration of findings, as reflected in the distinct cluster structures observed in co-citation networks. Temporal analysis indicates an encouraging trend toward diversification since 2019, with the emergence of new countries, institutions, and researchers entering the field. However, achieving truly equitable and deeply integrated global research collaboration remains challenging. Future efforts should prioritize the development of inclusive partnerships that account for varied regional disease burdens and clinical needs. Strategic resource allocation and policy support should aim to foster methodologically robust, translatable, and equitable research partnerships that can address both global priorities and locally relevant questions in LT and sarcopenia.

The three most cited and co-cited references are identical, underscoring their foundational role in this field. The study by Englesbe et al. was among the first to systematically establish a robust correlation between sarcopenia and post-LT mortality, proposing sarcopenia as an objective marker of patient frailty with potential implications for clinical decision-making and organ allocation policies [43]. Montano-loza et al. further articulated the prognostic impact of muscle wasting in patients with cirrhosis, stimulating subsequent research into mechanisms, diagnostics, and interventions in this subpopulation [44]. Tandon et al. provided the first systematic assessment of sarcopenia prevalence among patients on the LT waitlist and demonstrated its independent prognostic value superior to conventional nutritional metrics such as BMI [45]. These three highly cited/co-cited references established the foundation for sarcopenia research in LT, triggering a wave of related studies. Furthermore, dual-map analysis reveals that research themes on LT and sarcopenia have evolved from an initial focus on pharmacological and clinical aspects toward molecular mechanisms, public health, and integrated therapeutic strategies (Figure 5c). This shift emphasizes the growing importance of multidisciplinary approaches and suggests a future research trajectory increasingly oriented toward mechanistic insight and translational applications.

In CiteSpace, modularity (Q-index) and weighted mean silhouettes (S-index) are used to evaluate the overall framework performance of keyword clustering networks. A Q-value >0.3 is regarded as an indication of a strong network structure. The credibility threshold is set as follows: an S-value >0.5 is considered moderate and reasonable and an S-value >0.7 is highly credible [46]. In our study, the Q-value was 0.7615 and the S-value was 0.9314, suggesting a robust and highly credible clustering network (Figure 7a). This network illustrated that research in the field primarily focused on four aspects: liver diseases, tumors, risk factors and prognosis, and molecular mechanisms. Early studies primarily centered on the prevalence of sarcopenia and its impact on the prognosis of LT patients. Carey et al. defined sarcopenia in patients with end-stage liver disease through a multicenter study and explored its prognostic implications [47]. Golse et al. proposed a new definition of sarcopenia in LT patients and suggested diagnostic criteria based on CT imaging [48]. As research advanced, scholars began to investigate the pathogenesis of sarcopenia, including hepatic–muscle axis mediators (e.g., hyperammonemia, low growth hormone levels, endotoxemia, etc.) [4951], as well as the role of gut microbiota [52]. In recent years, research has gradually shifted toward clinical interventions such as nutritional support, resistance training, and hormone supplementation to improve the prognosis of sarcopenic patients [53]. Current research hotpots and trends have shifted from a broad form to a more detailed one. The proposal of novel scoring models, such as the MELD-sarcopenia scoring model [54] and sarco-model (MELD-Na + sarcopenia) [55], scientifically underscored the significance of incorporating sarcopenia into LT evaluation systems and clinical decision-making for liver allocation. Bi et al. explored the application of artificial intelligence in cancer imaging, offering new insights for the radiological assessment of sarcopenia [56]. Kim et al. developed a machine learning model for sarcopenia identification based on muscle radiomics features [57]. Additionally, Chinese researchers have made unique contributions to LT for hepatocellular carcinoma (HCC), with Xiao et al. identifying chitinase-3-like protein 1 (CHI3L1) as a biomarker associated with both sarcopenia and tumor recurrence risk [58,59]. They also proposed using radiomics to assess the degree of sarcopenia in HCC patients [60]. Future research will increasingly focus on the precise, diversified, and intelligent assessment of sarcopenia, integrating radiomics and artificial intelligence technologies to further optimize prognostic prediction models. The research paradigm in this field is undergoing a profound shift from “phenomenological observation” to “mechanistic dissection” and finally to “precision intervention.”

Currently, the mechanistic research on sarcopenia in the domain of LT is still in its preliminary stages. Inter-organ interactions have become a novel research focus. Studies suggest that the gut–liver–muscle axis mediates a multi-organ interaction, which is a critical factor in the onset and progression of sarcopenia. The specific mechanisms include: (1) impaired liver function leading to hyperammonemia, which inhibits muscle synthesis, activates muscle autophagy, and enhances the ubiquitin–proteasome pathway, thereby accelerating muscle breakdown [49]. (2) Low levels of growth hormone resulting in reduced muscle protein synthesis, further exacerbating sarcopenia [50]. (3) Cirrhotic patients frequently endure gut microbiota dysbiosis and endotoxemia, where the former indirectly affects muscle metabolism through modulation of gut barrier function and immune regulation, while the latter activates inflammatory pathways that inhibit muscle synthesis and promote muscle breakdown [51,52]. (4) Fibroblast growth factor 21 (FGF21) may influence muscle mass by regulating mitochondrial function and energy metabolism [61]. Although these studies have revealed some of the mechanisms of sarcopenia in LT, the overall mechanism remains ambiguous. Our bioinformatics findings push this understanding to a broader dimension. The 78 dual-phenotype target genes and 20 hub genes (e.g., IL1B, ADIPOQ, etc.) we identified do not function in isolation but are intensively enriched in several highly interconnected functional modules: 1) The Immunometabolism Cross-Talk Network: the intertwining of insulin resistance and anti-inflammatory response pathways mediated by IL-4/IL-10/IL-13 suggests that the chronic inflammatory microenvironment may directly disrupt muscle homeostasis by modulating insulin sensitivity and lipid metabolism (ADIPOQ function). This provides a novel mechanism for understanding the link between cirrhosis-associated metabolic disorders and sarcopenia. 2) The Cellular Stress and Survival Regulation Network: pathways such as TP53, FOXO, AMPK, and HIF-1 constitute a core regulatory module responding to energy crisis, oxidative stress, and DNA damage. We hypothesize that various perioperative stressors in LT (ischemia–reperfusion injury, metabolic disorders, and infection [6]) may synergistically activate this network, inducing mitochondrial dysfunction and protein degradation, thereby exacerbating or triggering muscle wasting. This moves beyond the traditional nutritional explanation framework, positioning sarcopenia as a manifestation of a systemic stress response in muscle tissues. 3) Potential Inter-organ Communication Mechanisms: Factors like FGF21 may not only be metabolically active hormones secreted by the liver but also key messengers in inter-organ crosstalk. These findings collectively paint a picture far more complex than the “liver–muscle axis,” hinting at a “multi-organ network disease” model involving the liver, gut, immune system, adipose tissues, and muscles. This lays a solid theoretical foundation for developing future combination interventions targeting specific pathways (e.g., modulating FOXO activity, improving insulin sensitivity, or targeting specific inflammatory factors). Furthermore, our study also raised a key scientific question: Does the predominant mechanism of sarcopenia vary based on its etiology and population? In HCC-associated sarcopenia, activation of the TP53 pathway might simultaneously drive carcinogenesis and muscle atrophy, forming a “comorbid” mechanism. While the role of CHI3L1 [59,60] suggested a previously unrecognized interaction between the tumor microenvironment and muscle metabolism. Therefore, future research must emphasize population specificity and develop precise phenotyping, rather than treating sarcopenia as a single disease.

Looking forward, this study points to several highly promising directions: first, leveraging multi-omics data integration to further elucidate the dynamic expression changes of these hub genes before and after LT and their causal relationship with clinical outcomes. Second, exploring the integration of radiomics and biomarkers could help build a “digital biopsy” predictive model that reflects both macro-morphology and micro-function. Third, promoting mechanism-oriented clinical trials: our findings strongly suggest that future interventions should not be limited to nutritional support or exercise alone but should consider testing the effectiveness of combination therapies targeting immunometabolism (e.g., anti-inflammatory nutritional formulations, insulin sensitizers) or modulating cellular stress (e.g., AMPK activators) in the LT perioperative period.

Certainly, recognizing the limitations of the study is critical for determining future research objectives. One significant issue is the reliance on retrospective data from a single database, which may not include the entire corpus of literature on LT and sarcopenia (selection bias). Second, the results of this study may be influenced by publication bias (i.e., studies with positive results are more likely to be published). Furthermore, the mechanisms inferred from bioinformatics require functional validation and causal confirmation through in vitro cell models, genetically modified animal experiments, and prospective clinical studies. Future research should concentrate on multi-center collaborations involving diverse patient populations to enhance the generalizability of findings. Moreover, prospective studies are required to investigate the temporal dynamics of muscle mass changes in LT patients and their implications on recovery and survival, filling the major gaps revealed in our research.

5 Conclusions

This work integrates bibliometric and bioinformatics approaches to comprehensively evaluate the literature on LT and sarcopenia, uncovering the key research trends, shared biomarkers, and potential pathological processes. Both illnesses share numerous similarities in etiology and progression but may also engage in reciprocal aggravation, forming a complex vicious cycle. Nevertheless, high-quality evidence elucidating their mechanistic interplay remains limited. Moving forward, research should prioritize the convergence of mechanistic exploration and clinical translation, which will be essential to advancing the field and improving prognostic outcomes for affected patients.

  1. Funding information: This study was supported by the Natural Science Foundation of Ningbo (2023J221), the Medical and Health Research Project of Zhejiang Province (2024KY1480), the Traditional Chinese Medicine Research Project of Zhejiang Province (2025ZL524), and the Ningbo Public Welfare Science and Technology Project (2024S159).

  2. Author contributions: L.D.: conceptualization and writing – original draft preparation; Y.X.: charting and methodology; L.D.: data analysis and visualization; Y.L. and X.Y.Y.: reference acquisition; J.H.: comments and suggestions; C.J.L.: manuscript revision and funding acquisition. All the authors approved the final manuscript.

  3. Conflict of interest: Authors state no conflict of interest.

  4. Data availability statement: The datasets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request.

References

[1] Samuel D, De Martin E, Berg T, Berenguer M, Burra P, Fondevila C, et al. EASL clinical practice guidelines on liver transplantation. J Hepatol. 2024;81(6):1040–86.10.1016/j.jhep.2024.07.032Search in Google Scholar PubMed

[2] Olivo R, Guarrera JV, Pyrsopoulos NT. Liver transplantation for acute liver failure. Clin Liver Dis. 2018;22(2):409–17.10.1016/j.cld.2018.01.014Search in Google Scholar PubMed

[3] Kohli R, Cortes M, Heaton ND, Dhawan A. Liver transplantation in children: state of the art and future perspectives. Arch Dis Child. 2018;103(2):192–8.10.1136/archdischild-2015-310023Search in Google Scholar PubMed

[4] Sugawara Y, Hibi T. Recent trends and new developments in liver transplantation. Biosci Trends. 2024;18(3):206–11.10.5582/bst.2024.01176Search in Google Scholar PubMed

[5] Honerkamp I, Sandmann L, Richter N, Manns MP, Voigtländer T, Vondran FWR, et al. Surgical procedures in patients awaiting liver transplantation: Complications and impact on the liver function. J Clin Exp Hepatol. 2022;12(1):68–79.10.1016/j.jceh.2021.03.011Search in Google Scholar PubMed PubMed Central

[6] Vidot H, Kline K, Cheng R, Finegan L, Lin A, Kempler E, et al. The relationship of obesity, nutritional status and muscle wasting in patients assessed for liver transplantation. Nutrients. 2019;11(9):2097.10.3390/nu11092097Search in Google Scholar PubMed PubMed Central

[7] Fukuhara S, Kobayashi T, Hamaoka M, Naruhiko H, Oishi K, Namba Y, et al. Sarcopenia’s impact defined by grip strength and muscle mass on post-hepatectomy outcomes: A multicenter analysis. Vivo. 2024;38(6):2827–35.10.21873/invivo.13763Search in Google Scholar PubMed PubMed Central

[8] Cruz-Jentoft AJ, Bahat G, Bauer J, Boirie Y, Bruyère O, Cederholm T, et al. Sarcopenia: Revised European consensus on definition and diagnosis. Age Ageing. 2019;48(1):16–31.10.1093/ageing/afy169Search in Google Scholar PubMed PubMed Central

[9] Shimura Y, Kuramitsu K, Kido M, Komatsu S, Gon H, Fukushima K, et al. Factors predicting over-time weight increase after liver transplantation: A retrospective study. Transpl Proc. 2023;55(4):924–9.10.1016/j.transproceed.2023.03.045Search in Google Scholar PubMed

[10] Wiedmer P, Jung T, Castro JP, Pomatto LCD, Sun PY, Davies KJA, et al. Sarcopenia - Molecular mechanisms and open questions. Ageing Res Rev. 2021;65:101200.10.1016/j.arr.2020.101200Search in Google Scholar PubMed

[11] Eguchi Y, Suzuki M, Yamanaka H, Tamai H, Kobayashi T, Orita S, et al. Influence of skeletal muscle mass and spinal alignment on surgical outcomes for lumbar spinal stenosis. Asian Spine J. 2018;12(3):556–62.10.4184/asj.2018.12.3.556Search in Google Scholar PubMed PubMed Central

[12] Jeong D, Lee SW, Jang HY, Kwon HM, Shin WJ, Song IK. Preoperative low muscle mass and early postoperative outcomes in children undergoing living donor liver transplantation: A retrospective study. Liver Transpl. 2024;30(1):83–93.10.1097/LVT.0000000000000230Search in Google Scholar PubMed

[13] Farquhar R, Matthews S, Baxter N, Rayers G, Ratnayake CBB, Robertson FP, et al. Sarcopenia and sarcopenic obesity on body composition analysis is a significant predictor of mortality in severe acute pancreatitis: A longitudinal observational study. World J Surg. 2023;47(11):2825–33.10.1007/s00268-023-07122-1Search in Google Scholar PubMed PubMed Central

[14] Ulugerger Avci G, Bektan Kanat B, Can G, Suzan V, Unal D, Degirmenci P, et al. The impact of sarcopenia and obesity on mortality of older adults: Five years results. Ir J Med Sci. 2023;192(5):2209–16.10.1007/s11845-023-03392-9Search in Google Scholar PubMed

[15] Yu DG, Xu L. Impact evaluations of articles in current drug delivery based on web of science. Curr Drug Deliv. 2024;21(3):360–7.10.2174/1567201820666230508115356Search in Google Scholar PubMed

[16] Giménez-Espert MDC, Prado-Gascó VJ. Bibliometric analysis of six nursing journals from the Web of Science, 2012–2017. J Adv Nurs. 2019;75(3):543–54.10.1111/jan.13868Search in Google Scholar PubMed

[17] He T, Zou J, Sun K, Yang J. Global research status and frontiers on autophagy in hepatocellular carcinoma: a comprehensive bibliometric and visualized analysis. Int J Surg. 2024;110(5):2788–802.10.1097/JS9.0000000000001202Search in Google Scholar PubMed PubMed Central

[18] Jiang T, Lin T, Shu X, Song Q, Dai M, Zhao Y, et al. Prevalence and prognostic value of preexisting sarcopenia in patients with mechanical ventilation: A systematic review and meta-analysis. Crit Care. 2022;26(1):140.10.1186/s13054-022-04015-ySearch in Google Scholar PubMed PubMed Central

[19] Lin T, Dai M, Xu P, Sun L, Shu X, Xia X, et al. Prevalence of sarcopenia in pain patients and correlation between the two conditions: A systematic review and meta-analysis. J Am Med Dir Assoc. 2022;23(5):902.e1–.e20.10.1016/j.jamda.2022.02.005Search in Google Scholar PubMed

[20] Li J, Wu G, Zhang Y, Shi W. Optimizing flood predictions by integrating LSTM and physical-based models with mixed historical and simulated data. Heliyon. 2024;10(13):e33669.10.1016/j.heliyon.2024.e33669Search in Google Scholar PubMed PubMed Central

[21] Vivaudou M. eeFit: A microsoft excel-embedded program for interactive analysis and fitting of experimental dose-response data. Biotechniques. 2019;66(4):186–93.10.2144/btn-2018-0136Search in Google Scholar PubMed

[22] Zhang L, Zheng H, Jiang ST, Liu YG, Zhang T, Zhang JW, et al. Worldwide research trends on tumor burden and immunotherapy: A bibliometric analysis. Int J Surg. 2024;110(3):1699–710.10.1097/JS9.0000000000001022Search in Google Scholar PubMed PubMed Central

[23] Wang J, Shahzad F. A visualized and scientometric analysis of health literacy research. Front Public Health. 2021;9:811707.10.3389/fpubh.2021.811707Search in Google Scholar PubMed PubMed Central

[24] Liaqat W, Altaf MT, Barutçular C, Zayed EM, Hussain T. Drought and sorghum: A bibliometric analysis using VOS viewer. J Biomol Struct Dyn. 2024;42(22):12317–29.10.1080/07391102.2023.2269279Search in Google Scholar PubMed

[25] Ye L, Liang R, Liu X, Li J, Yue J, Zhang X. Frailty and sarcopenia: A bibliometric analysis of their association and potential targets for intervention. Ageing Res Rev. 2023;92:102111.10.1016/j.arr.2023.102111Search in Google Scholar PubMed

[26] Zhou L, Min Y, Cao Q, Tan X, Cui Y, Wang J. Comprehensive analysis of the value of angiogenesis and stemness-related genes in the prognosis and immunotherapy of ovarian cancer. Biofactors. 2025;51(1):e2155.10.1002/biof.2155Search in Google Scholar PubMed PubMed Central

[27] Dai L, Mugaanyi J, Cai X, Lu C, Lu C. Pancreatic adenocarcinoma associated immune-gene signature as a novo risk factor for clinical prognosis prediction in hepatocellular carcinoma. Sci Rep. 2022;12(1):11944.10.1038/s41598-022-16155-wSearch in Google Scholar PubMed PubMed Central

[28] Schriml LM, Munro JB, Schor M, Olley D, McCracken C, Felix V, et al. The human disease ontology 2022 update. Nucleic acids Res. 2022;50(D1):D1255–d61.10.1093/nar/gkab1063Search in Google Scholar PubMed PubMed Central

[29] Szklarczyk D, Kirsch R, Koutrouli M, Nastou K, Mehryary F, Hachilif R, et al. The STRING database in 2023: Protein-protein association networks and functional enrichment analyses for any sequenced genome of interest. Nucleic acids Res. 2023;51(D1):D638–d46.10.1093/nar/gkac1000Search in Google Scholar PubMed PubMed Central

[30] Milacic M, Beavers D, Conley P, Gong C, Gillespie M, Griss J, et al. The reactome pathway knowledgebase 2024. Nucleic Acids Res. 2024;52(D1):D672–d8.10.1093/nar/gkad1025Search in Google Scholar PubMed PubMed Central

[31] Wakabayashi H. Hospital-associated sarcopenia, acute sarcopenia, and iatrogenic sarcopenia: Prevention of sarcopenia during hospitalization. J Gen Fam Med. 2023;24(3):146–7.10.1002/jgf2.625Search in Google Scholar PubMed PubMed Central

[32] Kuzuya M. Drug-related sarcopenia as a secondary sarcopenia. Geriatr Gerontol Int. 2024;24(2):195–203.10.1111/ggi.14770Search in Google Scholar PubMed PubMed Central

[33] Tırnova İ, Gasimova M, Akay H, Sarıtürk Ç, Güven Mert A, Yenidünya Ö, et al. Low skeletal muscle mass as a proxy marker of sarcopenia is a risk factor for major complications in older patients undergoing curative colon resections for colon cancer. Front Med (Lausanne). 2024;11:1464978.10.3389/fmed.2024.1464978Search in Google Scholar PubMed PubMed Central

[34] Saeki C, Tsubota A. Influencing factors and molecular pathogenesis of sarcopenia and osteosarcopenia in chronic liver disease. Life (Basel). 2021;11(9):899.10.3390/life11090899Search in Google Scholar PubMed PubMed Central

[35] Damluji AA, Alfaraidhy M, AlHajri N, Rohant NN, Kumar M, Al Malouf C, et al. Sarcopenia and cardiovascular diseases. Circulation. 2023;147(20):1534–53.10.1161/CIRCULATIONAHA.123.064071Search in Google Scholar PubMed PubMed Central

[36] Meza-Valderrama D, Marco E, Dávalos-Yerovi V, Muns MD, Tejero-Sánchez M, Duarte E, et al. Sarcopenia, malnutrition, and cachexia: Adapting definitions and terminology of nutritional disorders in older people with cancer. Nutrients. 2021;13(3):761.10.3390/nu13030761Search in Google Scholar PubMed PubMed Central

[37] Campos-Varela I, Castells L, Quiroga S, Vargas V, Simon-Talero M. Frailty and sarcopenia in patients with acute-on-chronic liver failure: Assessment and risk in the liver transplant setting. Ann Hepatol. 2024;29(5):101515.10.1016/j.aohep.2024.101515Search in Google Scholar PubMed

[38] Zhou D, Zhang D, Zeng C, Zhang L, Gao X, Wang X. Impact of sarcopenia on the survival of patients undergoing liver transplantation for decompensated liver cirrhosis. J Cachexia Sarcopenia Muscle. 2023;14(6):2602–12.10.1002/jcsm.13334Search in Google Scholar PubMed PubMed Central

[39] Wahlen BM, Mekkodathil A, Al-Thani H, El-Menyar A. Impact of sarcopenia in trauma and surgical patient population: A literature review. Asian J Surg. 2020;43(6):647–53.10.1016/j.asjsur.2019.10.010Search in Google Scholar PubMed

[40] Wilkinson DJ, Piasecki M, Atherton PJ. The age-related loss of skeletal muscle mass and function: Measurement and physiology of muscle fibre atrophy and muscle fibre loss in humans. Ageing Res Rev. 2018;47:123–32.10.1016/j.arr.2018.07.005Search in Google Scholar PubMed PubMed Central

[41] Fujii W, Wada H, Hasegawa S, Mukai Y, Asukai K, Akita H, et al. Clinical impact of body composition on postoperative outcomes during neoadjuvant chemoradiation therapy for distal bile duct cancer. Mol Clin Oncol. 2022;16(6):109.10.3892/mco.2022.2542Search in Google Scholar PubMed PubMed Central

[42] de Pinho Favaro MT, Atienza-Garriga J, Martínez-Torró C, Parladé E, Vázquez E, Corchero JL, et al. Recombinant vaccines in 2022: A perspective from the cell factory. Microb Cell Fact. 2022;21(1):203.10.1186/s12934-022-01929-8Search in Google Scholar PubMed PubMed Central

[43] Englesbe MJ, Patel SP, He K, Lynch RJ, Schaubel DE, Harbaugh C, et al. Sarcopenia and mortality after liver transplantation. J Am Coll Surg. 2010;211(2):271–8.10.1016/j.jamcollsurg.2010.03.039Search in Google Scholar PubMed PubMed Central

[44] Montano-Loza AJ, Meza-Junco J, Prado CM, Lieffers JR, Baracos VE, Bain VG, et al. Muscle wasting is associated with mortality in patients with cirrhosis. Clin Gastroenterol Hepatol. 2012;10(2):166–73, 73.e1.10.1016/j.cgh.2011.08.028Search in Google Scholar PubMed

[45] Tandon P, Ney M, Irwin I, Ma MM, Gramlich L, Bain VG, et al. Severe muscle depletion in patients on the liver transplant wait list: Its prevalence and independent prognostic value. Liver Transpl. 2012;18(10):1209–16.10.1002/lt.23495Search in Google Scholar PubMed

[46] Wang W, Wang H, Yao T, Li Y, Yi L, Gao Y, et al. The top 100 most cited articles on COVID-19 vaccine: A bibliometric analysis. Clin Exp Med. 2023;23(6):2287–99.10.1007/s10238-023-01046-9Search in Google Scholar PubMed PubMed Central

[47] Carey EJ, Lai JC, Wang CW, Dasarathy S, Lobach I, Montano-Loza AJ, et al. A multicenter study to define sarcopenia in patients with end-stage liver disease. Liver Transpl. 2017;23(5):625–33.10.1002/lt.24750Search in Google Scholar PubMed PubMed Central

[48] Golse N, Bucur PO, Ciacio O, Pittau G, Sa Cunha A, Adam R, et al. A new definition of sarcopenia in patients with cirrhosis undergoing liver transplantation. Liver Transpl. 2017;23(2):143–54.10.1002/lt.24671Search in Google Scholar PubMed

[49] Dasarathy S, Merli M. Sarcopenia from mechanism to diagnosis and treatment in liver disease. J Hepatol. 2016;65(6):1232–44.10.1016/j.jhep.2016.07.040Search in Google Scholar PubMed PubMed Central

[50] Ponziani FR, Picca A, Marzetti E, Calvani R, Conta G, Del Chierico F, et al. Characterization of the gut-liver-muscle axis in cirrhotic patients with sarcopenia. Liver Int: Off J International Assoc Study Liver. 2021;41(6):1320–34.10.1111/liv.14876Search in Google Scholar PubMed

[51] Ohsawa Y, Ohtsubo H, Munekane A, Ohkubo K, Murakami T, Fujino M, et al. Circulating α-Klotho counteracts transforming growth factor-β-induced sarcopenia. Am J Pathol. 2023;193(5):591–607.10.1016/j.ajpath.2023.01.009Search in Google Scholar PubMed

[52] Zhang T, Cheng JK, Hu YM. Gut microbiota as a promising therapeutic target for age-related sarcopenia. Ageing Res Rev. 2022;81:101739.10.1016/j.arr.2022.101739Search in Google Scholar PubMed

[53] Kamo N, Kaido T, Uozumi R, Ito T, Yagi S, Hata K, et al. Effect of administration of β-hydroxy-β-methyl butyrate-enriched formula after liver transplantation: A pilot randomized controlled trial. Nutrition. 2020;79-80:110871.10.1016/j.nut.2020.110871Search in Google Scholar PubMed

[54] van Vugt JLA, Alferink LJM, Buettner S, Gaspersz MP, Bot D, Darwish Murad S, et al. A model including sarcopenia surpasses the MELD score in predicting waiting list mortality in cirrhotic liver transplant candidates: A competing risk analysis in a national cohort. J Hepatol. 2018;68(4):707–14.10.1016/j.jhep.2017.11.030Search in Google Scholar PubMed

[55] Lai Q, Magistri P, Lionetti R, Avolio AW, Lenci I, Giannelli V, et al. Sarco-Model: A score to predict the dropout risk in the perspective of organ allocation in patients awaiting liver transplantation. Liver Int: Off J International Assoc Study Liver. 2021;41(7):1629–40.10.1111/liv.14889Search in Google Scholar PubMed

[56] Bi WL, Hosny A, Schabath MB, Giger ML, Birkbak NJ, Mehrtash A, et al. Artificial intelligence in cancer imaging: Clinical challenges and applications. CA Cancer J Clin. 2019;69(2):127–57.10.3322/caac.21552Search in Google Scholar PubMed PubMed Central

[57] Kim YJ. Machine learning models for sarcopenia identification based on radiomic features of muscles in computed tomography. Int J Env Res Public Health. 2021;18(16):8710.10.3390/ijerph18168710Search in Google Scholar PubMed PubMed Central

[58] Lu D, Lin Z, Wang R, Chen Z, Zhuo J, Xu L, et al. Multi-omics profiling reveals Chitinase-3-like protein 1 as a key mediator in the crosstalk between sarcopenia and liver cancer. Redox Biol. 2022;58:102538.10.1016/j.redox.2022.102538Search in Google Scholar PubMed PubMed Central

[59] Lu D, Hu Z, Chen H, Khan AA, Xu Q, Lin Z, et al. Myosteatosis and muscle loss impact liver transplant outcomes in male patients with hepatocellular carcinoma. J Cachexia Sarcopenia Muscle. 2024;15(5):2071–83.10.1002/jcsm.13554Search in Google Scholar PubMed PubMed Central

[60] Liu Z, Wu Y, Khan AA, Lun LU, Wang J, Chen J, et al. Deep learning-based radiomics allows for a more accurate assessment of sarcopenia as a prognostic factor in hepatocellular carcinoma. J Zhejiang Univ Sci B. 2024;25(1):83–90.10.1631/jzus.B2300363Search in Google Scholar PubMed PubMed Central

[61] Oost LJ, Kustermann M, Armani A, Blaauw B, Romanello V. Fibroblast growth factor 21 controls mitophagy and muscle mass. J Cachexia Sarcopenia Muscle. 2019;10(3):630–42.10.1002/jcsm.12409Search in Google Scholar PubMed PubMed Central

Received: 2025-07-09
Revised: 2025-09-01
Accepted: 2025-09-08
Published Online: 2025-10-27

© 2025 the author(s), published by De Gruyter

This work is licensed under the Creative Commons Attribution 4.0 International License.

Articles in the same Issue

  1. Biomedical Sciences
  2. Mechanism of triptolide regulating proliferation and apoptosis of hepatoma cells by inhibiting JAK/STAT pathway
  3. Maslinic acid improves mitochondrial function and inhibits oxidative stress and autophagy in human gastric smooth muscle cells
  4. Comparative analysis of inflammatory biomarkers for the diagnosis of neonatal sepsis: IL-6, IL-8, SAA, CRP, and PCT
  5. Post-pandemic insights on COVID-19 and premature ovarian insufficiency
  6. Proteome differences of dental stem cells between permanent and deciduous teeth by data-independent acquisition proteomics
  7. Optimizing a modified cetyltrimethylammonium bromide protocol for fungal DNA extraction: Insights from multilocus gene amplification
  8. Preliminary analysis of the role of small hepatitis B surface proteins mutations in the pathogenesis of occult hepatitis B infection via the endoplasmic reticulum stress-induced UPR-ERAD pathway
  9. Efficacy of alginate-coated gold nanoparticles against antibiotics-resistant Staphylococcus and Streptococcus pathogens of acne origins
  10. Battling COVID-19 leveraging nanobiotechnology: Gold and silver nanoparticle–B-escin conjugates as SARS-CoV-2 inhibitors
  11. Neurodegenerative diseases and neuroinflammation-induced apoptosis
  12. Impact of fracture fixation surgery on cognitive function and the gut microbiota in mice with a history of stroke
  13. COLEC10: A potential tumor suppressor and prognostic biomarker in hepatocellular carcinoma through modulation of EMT and PI3K-AKT pathways
  14. High-temperature requirement serine protease A2 inhibitor UCF-101 ameliorates damaged neurons in traumatic brain-injured rats by the AMPK/NF-κB pathway
  15. SIK1 inhibits IL-1β-stimulated cartilage apoptosis and inflammation in vitro through the CRTC2/CREB1 signaling
  16. Rutin–chitooligosaccharide complex: Comprehensive evaluation of its anti-inflammatory and analgesic properties in vitro and in vivo
  17. Knockdown of Aurora kinase B alleviates high glucose-triggered trophoblast cells damage and inflammation during gestational diabetes
  18. Calcium-sensing receptors promoted Homer1 expression and osteogenic differentiation in bone marrow mesenchymal stem cells
  19. ABI3BP can inhibit the proliferation, invasion, and epithelial–mesenchymal transition of non-small-cell lung cancer cells
  20. Changes in blood glucose and metabolism in hyperuricemia mice
  21. Rapid detection of the GJB2 c.235delC mutation based on CRISPR-Cas13a combined with lateral flow dipstick
  22. IL-11 promotes Ang II-induced autophagy inhibition and mitochondrial dysfunction in atrial fibroblasts
  23. Short-chain fatty acid attenuates intestinal inflammation by regulation of gut microbial composition in antibiotic-associated diarrhea
  24. Application of metagenomic next-generation sequencing in the diagnosis of pathogens in patients with diabetes complicated by community-acquired pneumonia
  25. NAT10 promotes radiotherapy resistance in non-small cell lung cancer by regulating KPNB1-mediated PD-L1 nuclear translocation
  26. Phytol-mixed micelles alleviate dexamethasone-induced osteoporosis in zebrafish: Activation of the MMP3–OPN–MAPK pathway-mediating bone remodeling
  27. Association between TGF-β1 and β-catenin expression in the vaginal wall of patients with pelvic organ prolapse
  28. Primary pleomorphic liposarcoma involving bilateral ovaries: Case report and literature review
  29. Effects of de novo donor-specific Class I and II antibodies on graft outcomes after liver transplantation: A pilot cohort study
  30. Sleep architecture in Alzheimer’s disease continuum: The deep sleep question
  31. Ephedra fragilis plant extract: A groundbreaking corrosion inhibitor for mild steel in acidic environments – electrochemical, EDX, DFT, and Monte Carlo studies
  32. Langerhans cell histiocytosis in an adult patient with upper jaw and pulmonary involvement: A case report
  33. Inhibition of mast cell activation by Jaranol-targeted Pirin ameliorates allergic responses in mouse allergic rhinitis
  34. Aeromonas veronii-induced septic arthritis of the hip in a child with acute lymphoblastic leukemia
  35. Clusterin activates the heat shock response via the PI3K/Akt pathway to protect cardiomyocytes from high-temperature-induced apoptosis
  36. Research progress on fecal microbiota transplantation in tumor prevention and treatment
  37. Low-pressure exposure influences the development of HAPE
  38. Stigmasterol alleviates endplate chondrocyte degeneration through inducing mitophagy by enhancing PINK1 mRNA acetylation via the ESR1/NAT10 axis
  39. AKAP12, mediated by transcription factor 21, inhibits cell proliferation, metastasis, and glycolysis in lung squamous cell carcinoma
  40. Association between PAX9 or MSX1 gene polymorphism and tooth agenesis risk: A meta-analysis
  41. A case of bloodstream infection caused by Neisseria gonorrhoeae
  42. Case of nasopharyngeal tuberculosis complicated with cervical lymph node and pulmonary tuberculosis
  43. p-Cymene inhibits pro-fibrotic and inflammatory mediators to prevent hepatic dysfunction
  44. GFPT2 promotes paclitaxel resistance in epithelial ovarian cancer cells via activating NF-κB signaling pathway
  45. Transfer RNA-derived fragment tRF-36 modulates varicose vein progression via human vascular smooth muscle cell Notch signaling
  46. RTA-408 attenuates the hepatic ischemia reperfusion injury in mice possibly by activating the Nrf2/HO-1 signaling pathway
  47. Decreased serum TIMP4 levels in patients with rheumatoid arthritis
  48. Sirt1 protects lupus nephritis by inhibiting the NLRP3 signaling pathway in human glomerular mesangial cells
  49. Sodium butyrate aids brain injury repair in neonatal rats
  50. Interaction of MTHFR polymorphism with PAX1 methylation in cervical cancer
  51. Convallatoxin inhibits proliferation and angiogenesis of glioma cells via regulating JAK/STAT3 pathway
  52. The effect of the PKR inhibitor, 2-aminopurine, on the replication of influenza A virus, and segment 8 mRNA splicing
  53. Effects of Ire1 gene on virulence and pathogenicity of Candida albicans
  54. Small cell lung cancer with small intestinal metastasis: Case report and literature review
  55. GRB14: A prognostic biomarker driving tumor progression in gastric cancer through the PI3K/AKT signaling pathway by interacting with COBLL1
  56. 15-Lipoxygenase-2 deficiency induces foam cell formation that can be restored by salidroside through the inhibition of arachidonic acid effects
  57. FTO alleviated the diabetic nephropathy progression by regulating the N6-methyladenosine levels of DACT1
  58. Clinical relevance of inflammatory markers in the evaluation of severity of ulcerative colitis: A retrospective study
  59. Zinc valproic acid complex promotes osteoblast differentiation and exhibits anti-osteoporotic potential
  60. Primary pulmonary synovial sarcoma in the bronchial cavity: A case report
  61. Metagenomic next-generation sequencing of alveolar lavage fluid improves the detection of pulmonary infection
  62. Uterine tumor resembling ovarian sex cord tumor with extensive rhabdoid differentiation: A case report
  63. Genomic analysis of a novel ST11(PR34365) Clostridioides difficile strain isolated from the human fecal of a CDI patient in Guizhou, China
  64. Effects of tiered cardiac rehabilitation on CRP, TNF-α, and physical endurance in older adults with coronary heart disease
  65. Changes in T-lymphocyte subpopulations in patients with colorectal cancer before and after acupoint catgut embedding acupuncture observation
  66. Modulating the tumor microenvironment: The role of traditional Chinese medicine in improving lung cancer treatment
  67. Alterations of metabolites related to microbiota–gut–brain axis in plasma of colon cancer, esophageal cancer, stomach cancer, and lung cancer patients
  68. Research on individualized drug sensitivity detection technology based on bio-3D printing technology for precision treatment of gastrointestinal stromal tumors
  69. CEBPB promotes ulcerative colitis-associated colorectal cancer by stimulating tumor growth and activating the NF-κB/STAT3 signaling pathway
  70. Oncolytic bacteria: A revolutionary approach to cancer therapy
  71. A de novo meningioma with rapid growth: A possible malignancy imposter?
  72. Diagnosis of secondary tuberculosis infection in an asymptomatic elderly with cancer using next-generation sequencing: Case report
  73. Hesperidin and its zinc(ii) complex enhance osteoblast differentiation and bone formation: In vitro and in vivo evaluations
  74. Research progress on the regulation of autophagy in cardiovascular diseases by chemokines
  75. Anti-arthritic, immunomodulatory, and inflammatory regulation by the benzimidazole derivative BMZ-AD: Insights from an FCA-induced rat model
  76. Immunoassay for pyruvate kinase M1/2 as an Alzheimer’s biomarker in CSF
  77. The role of HDAC11 in age-related hearing loss: Mechanisms and therapeutic implications
  78. Evaluation and application analysis of animal models of PIPNP based on data mining
  79. Therapeutic approaches for liver fibrosis/cirrhosis by targeting pyroptosis
  80. Fabrication of zinc oxide nanoparticles using Ruellia tuberosa leaf extract induces apoptosis through P53 and STAT3 signalling pathways in prostate cancer cells
  81. Haplo-hematopoietic stem cell transplantation and immunoradiotherapy for severe aplastic anemia complicated with nasopharyngeal carcinoma: A case report
  82. Modulation of the KEAP1-NRF2 pathway by Erianin: A novel approach to reduce psoriasiform inflammation and inflammatory signaling
  83. The expression of epidermal growth factor receptor 2 and its relationship with tumor-infiltrating lymphocytes and clinical pathological features in breast cancer patients
  84. Innovations in MALDI-TOF Mass Spectrometry: Bridging modern diagnostics and historical insights
  85. BAP1 complexes with YY1 and RBBP7 and its downstream targets in ccRCC cells
  86. Hypereosinophilic syndrome with elevated IgG4 and T-cell clonality: A report of two cases
  87. Electroacupuncture alleviates sciatic nerve injury in sciatica rats by regulating BDNF and NGF levels, myelin sheath degradation, and autophagy
  88. Polydatin prevents cholesterol gallstone formation by regulating cholesterol metabolism via PPAR-γ signaling
  89. RNF144A and RNF144B: Important molecules for health
  90. Analysis of the detection rate and related factors of thyroid nodules in the healthy population
  91. Artesunate inhibits hepatocellular carcinoma cell migration and invasion through OGA-mediated O-GlcNAcylation of ZEB1
  92. Endovascular management of post-pancreatectomy hemorrhage caused by a hepatic artery pseudoaneurysm: Case report and review of the literature
  93. Efficacy and safety of anti-PD-1/PD-L1 antibodies in patients with relapsed refractory diffuse large B-cell lymphoma: A meta-analysis
  94. SATB2 promotes humeral fracture healing in rats by activating the PI3K/AKT pathway
  95. Overexpression of the ferroptosis-related gene, NFS1, corresponds to gastric cancer growth and tumor immune infiltration
  96. Understanding risk factors and prognosis in diabetic foot ulcers
  97. Atractylenolide I alleviates the experimental allergic response in mice by suppressing TLR4/NF-kB/NLRP3 signalling
  98. FBXO31 inhibits the stemness characteristics of CD147 (+) melanoma stem cells
  99. Immune molecule diagnostics in colorectal cancer: CCL2 and CXCL11
  100. Inhibiting CXCR6 promotes senescence of activated hepatic stellate cells with limited proinflammatory SASP to attenuate hepatic fibrosis
  101. Cadmium toxicity, health risk and its remediation using low-cost biochar adsorbents
  102. Pulmonary cryptococcosis with headache as the first presentation: A case report
  103. Solitary pulmonary metastasis with cystic airspaces in colon cancer: A rare case report
  104. RUNX1 promotes denervation-induced muscle atrophy by activating the JUNB/NF-κB pathway and driving M1 macrophage polarization
  105. Morphometric analysis and immunobiological investigation of Indigofera oblongifolia on the infected lung with Plasmodium chabaudi
  106. The NuA4/TIP60 histone-modifying complex and Hr78 modulate the Lobe2 mutant eye phenotype
  107. Experimental study on salmon demineralized bone matrix loaded with recombinant human bone morphogenetic protein-2: In vitro and in vivo study
  108. A case of IgA nephropathy treated with a combination of telitacicept and half-dose glucocorticoids
  109. Analgesic and toxicological evaluation of cannabidiol-rich Moroccan Cannabis sativa L. (Khardala variety) extract: Evidence from an in vivo and in silico study
  110. Wound healing and signaling pathways
  111. Combination of immunotherapy and whole-brain radiotherapy on prognosis of patients with multiple brain metastases: A retrospective cohort study
  112. To explore the relationship between endometrial hyperemia and polycystic ovary syndrome
  113. Research progress on the impact of curcumin on immune responses in breast cancer
  114. Biogenic Cu/Ni nanotherapeutics from Descurainia sophia (L.) Webb ex Prantl seeds for the treatment of lung cancer
  115. Dapagliflozin attenuates atrial fibrosis via the HMGB1/RAGE pathway in atrial fibrillation rats
  116. Glycitein alleviates inflammation and apoptosis in keratinocytes via ROS-associated PI3K–Akt signalling pathway
  117. ADH5 inhibits proliferation but promotes EMT in non-small cell lung cancer cell through activating Smad2/Smad3
  118. Apoptotic efficacies of AgNPs formulated by Syzygium aromaticum leaf extract on 32D-FLT3-ITD human leukemia cell line with PI3K/AKT/mTOR signaling pathway
  119. Novel cuproptosis-related genes C1QBP and PFKP identified as prognostic and therapeutic targets in lung adenocarcinoma
  120. Bee venom promotes exosome secretion and alters miRNA cargo in T cells
  121. Treatment of pure red cell aplasia in a chronic kidney disease patient with roxadustat: A case report
  122. Comparative bioinformatics analysis of the Wnt pathway in breast cancer: Selection of novel biomarker panels associated with ER status
  123. Kynurenine facilitates renal cell carcinoma progression by suppressing M2 macrophage pyroptosis through inhibition of CASP1 cleavage
  124. RFX5 promotes the growth, motility, and inhibits apoptosis of gastric adenocarcinoma cells through the SIRT1/AMPK axis
  125. ALKBH5 exacerbates early cardiac damage after radiotherapy for breast cancer via m6A demethylation of TLR4
  126. Phytochemicals of Roman chamomile: Antioxidant, anti-aging, and whitening activities of distillation residues
  127. Circadian gene Cry1 inhibits the tumorigenicity of hepatocellular carcinoma by the BAX/BCL2-mediated apoptosis pathway
  128. The TNFR-RIPK1/RIPK3 signalling pathway mediates the effect of lanthanum on necroptosis of nerve cells
  129. Longitudinal monitoring of autoantibody dynamics in patients with early-stage non-small-cell lung cancer undergoing surgery
  130. The potential role of rutin, a flavonoid, in the management of cancer through modulation of cell signaling pathways
  131. Construction of pectinase gene engineering microbe and its application in tobacco sheets
  132. Construction of a microbial abundance prognostic scoring model based on intratumoral microbial data for predicting the prognosis of lung squamous cell carcinoma
  133. Sepsis complicated by haemophagocytic lymphohistiocytosis triggered by methicillin-resistant Staphylococcus aureus and human herpesvirus 8 in an immunocompromised elderly patient: A case report
  134. Sarcopenia in liver transplantation: A comprehensive bibliometric study of current research trends and future directions
  135. Advances in cancer immunotherapy and future directions in personalized medicine
  136. Can coronavirus disease 2019 affect male fertility or cause spontaneous abortion? A two-sample Mendelian randomization analysis
  137. Heat stroke associated with novel leukaemia inhibitory factor receptor gene variant in a Chinese infant
  138. PSME2 exacerbates ulcerative colitis by disrupting intestinal barrier function and promoting autophagy-dependent inflammation
  139. Hyperosmolar hyperglycemic state with severe hypernatremia coexisting with central diabetes insipidus: A case report and literature review
  140. Efficacy and mechanism of escin in improving the tissue microenvironment of blood vessel walls via anti-inflammatory and anticoagulant effects: Implications for clinical practice
  141. Merkel cell carcinoma: Clinicopathological analysis of three patients and literature review
  142. Genetic variants in VWF exon 26 and their implications for type 1 Von Willebrand disease in a Saudi Arabian population
  143. Lipoxin A4 improves myocardial ischemia/reperfusion injury through the Notch1-Nrf2 signaling pathway
  144. High levels of EPHB2 expression predict a poor prognosis and promote tumor progression in endometrial cancer
  145. Knockdown of SHP-2 delays renal tubular epithelial cell injury in diabetic nephropathy by inhibiting NLRP3 inflammasome-mediated pyroptosis
  146. Exploring the toxicity mechanisms and detoxification methods of Rhizoma Paridis
  147. Concomitant gastric carcinoma and primary hepatic angiosarcoma in a patient: A case report
  148. Ecology and Environmental Science
  149. Optimization and comparative study of Bacillus consortia for cellulolytic potential and cellulase enzyme activity
  150. The complete mitochondrial genome analysis of Haemaphysalis hystricis Supino, 1897 (Ixodida: Ixodidae) and its phylogenetic implications
  151. Epidemiological characteristics and risk factors analysis of multidrug-resistant tuberculosis among tuberculosis population in Huzhou City, Eastern China
  152. Indices of human impacts on landscapes: How do they reflect the proportions of natural habitats?
  153. Genetic analysis of the Siberian flying squirrel population in the northern Changbai Mountains, Northeast China: Insights into population status and conservation
  154. Diversity and environmental drivers of Suillus communities in Pinus sylvestris var. mongolica forests of Inner Mongolia
  155. Global assessment of the fate of nitrogen deposition in forest ecosystems: Insights from 15N tracer studies
  156. Fungal and bacterial pathogenic co-infections mainly lead to the assembly of microbial community in tobacco stems
  157. Influencing of coal industry related airborne particulate matter on ocular surface tear film injury and inflammatory factor expression in Sprague-Dawley rats
  158. Temperature-dependent development, predation, and life table of Sphaerophoria macrogaster (Thomson) (Diptera: Syrphidae) feeding on Myzus persicae (Sulzer) (Homoptera: Aphididae)
  159. Eleonora’s falcon trophic interactions with insects within its breeding range: A systematic review
  160. Agriculture
  161. Integrated analysis of transcriptome, sRNAome, and degradome involved in the drought-response of maize Zhengdan958
  162. Variation in flower frost tolerance among seven apple cultivars and transcriptome response patterns in two contrastingly frost-tolerant selected cultivars
  163. Heritability of durable resistance to stripe rust in bread wheat (Triticum aestivum L.)
  164. Molecular mechanism of follicular development in laying hens based on the regulation of water metabolism
  165. Animal Science
  166. Effect of sex ratio on the life history traits of an important invasive species, Spodoptera frugiperda
  167. Plant Sciences
  168. Hairpin in a haystack: In silico identification and characterization of plant-conserved microRNA in Rafflesiaceae
  169. Widely targeted metabolomics of different tissues in Rubus corchorifolius
  170. The complete chloroplast genome of Gerbera piloselloides (L.) Cass., 1820 (Carduoideae, Asteraceae) and its phylogenetic analysis
  171. Field trial to correlate mineral solubilization activity of Pseudomonas aeruginosa and biochemical content of groundnut plants
  172. Correlation analysis between semen routine parameters and sperm DNA fragmentation index in patients with semen non-liquefaction: A retrospective study
  173. Plasticity of the anatomical traits of Rhododendron L. (Ericaceae) leaves and its implications in adaptation to the plateau environment
  174. Effects of Piriformospora indica and arbuscular mycorrhizal fungus on growth and physiology of Moringa oleifera under low-temperature stress
  175. Effects of different sources of potassium fertiliser on yield, fruit quality and nutrient absorption in “Harward” kiwifruit (Actinidia deliciosa)
  176. Comparative efficiency and residue levels of spraying programs against powdery mildew in grape varieties
  177. The DREB7 transcription factor enhances salt tolerance in soybean plants under salt stress
  178. Using plant electrical signals of water hyacinth (Eichhornia crassipes) for water pollution monitoring
  179. Food Science
  180. Phytochemical analysis of Stachys iva: Discovering the optimal extract conditions and its bioactive compounds
  181. Review on role of honey in disease prevention and treatment through modulation of biological activities
  182. Computational analysis of polymorphic residues in maltose and maltotriose transporters of a wild Saccharomyces cerevisiae strain
  183. Optimization of phenolic compound extraction from Tunisian squash by-products: A sustainable approach for antioxidant and antibacterial applications
  184. Liupao tea aqueous extract alleviates dextran sulfate sodium-induced ulcerative colitis in rats by modulating the gut microbiota
  185. Toxicological qualities and detoxification trends of fruit by-products for valorization: A review
  186. Polyphenolic spectrum of cornelian cherry fruits and their health-promoting effect
  187. Optimizing the encapsulation of the refined extract of squash peels for functional food applications: A sustainable approach to reduce food waste
  188. Advancements in curcuminoid formulations: An update on bioavailability enhancement strategies curcuminoid bioavailability and formulations
  189. Impact of saline sprouting on antioxidant properties and bioactive compounds in chia seeds
  190. The dilemma of food genetics and improvement
  191. Bioengineering and Biotechnology
  192. Impact of hyaluronic acid-modified hafnium metalorganic frameworks containing rhynchophylline on Alzheimer’s disease
  193. Emerging patterns in nanoparticle-based therapeutic approaches for rheumatoid arthritis: A comprehensive bibliometric and visual analysis spanning two decades
  194. Application of CRISPR/Cas gene editing for infectious disease control in poultry
  195. Preparation of hafnium nitride-coated titanium implants by magnetron sputtering technology and evaluation of their antibacterial properties and biocompatibility
  196. Preparation and characterization of lemongrass oil nanoemulsion: Antimicrobial, antibiofilm, antioxidant, and anticancer activities
  197. Corrigendum
  198. Corrigendum to “Utilization of convolutional neural networks to analyze microscopic images for high-throughput screening of mesenchymal stem cells”
  199. Corrigendum to “Effects of Ire1 gene on virulence and pathogenicity of Candida albicans
  200. Retraction
  201. Retraction of “Down-regulation of miR-539 indicates poor prognosis in patients with pancreatic cancer”
Downloaded on 25.12.2025 from https://www.degruyterbrill.com/document/doi/10.1515/biol-2025-1197/html
Scroll to top button